Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kintor Pharmaceutical Ltd ( (HK:9939) ) has issued an announcement.
Kintor Pharmaceutical Limited announced an increase in shareholding by its Chairman, Dr. Youzhi Tong, who purchased 200,000 shares and exercised rights under 1,250,000 restricted share units, bringing his total interest to approximately 10.99% of the company’s issued share capital. This move reflects Dr. Tong’s confidence in the company’s growth potential and long-term investment value, as Kintor continues to focus on expanding its dermatology product line and exploring new markets for its cosmetic ingredients.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited is a company focused on the dermatology industry, primarily involved in the development and commercialization of cosmetics products. The company is actively expanding its product offerings and exploring new market opportunities, particularly in the area of functional cosmetic ingredients.
YTD Price Performance: 14.43%
Average Trading Volume: 3,698,500
Technical Sentiment Signal: Buy
Current Market Cap: HK$510.7M
Learn more about 9939 stock on TipRanks’ Stock Analysis page.